Today: 7 February 2026
Subscribe

Rio Tinto share price today: stock steadies after Thursday drop as Glencore clock ticks

Rio Tinto share price today: stock steadies after Thursday drop as Glencore clock ticks

Rio Tinto shares hovered near 6,487p in early London trading Friday after a volatile week marked by strong iron ore and copper output and takeover speculation involving Glencore. Pilbara iron ore shipments rose 7% to 91.3 million tonnes in the quarter, while copper output climbed 11%. Investors await a Feb. 5 deadline for a possible Glencore bid and full-year results on Feb. 19.
23 January 2026
····
Adani Enterprises shares slump 5% after Thursday bounce as valuation worries bite again

Adani Enterprises shares slump 5% after Thursday bounce as valuation worries bite again

Adani Enterprises fell 5.2% to 1,978.6 rupees on Friday, nearing its 52-week low after a brief rebound Thursday. The stock has dropped 5.6% over the past week and remains volatile, with a six-month beta near 2.93. Investors remain wary as analysts forecast a 10% annual earnings decline and the price-to-earnings ratio stands at 34.2. Other Adani group stocks also saw sharp moves following mixed earnings reports.
23 January 2026
··
Shell share price edges higher in London as Nigeria incentives and Argentina shale sale talk hit the tape

Shell share price edges higher in London as Nigeria incentives and Argentina shale sale talk hit the tape

Shell shares rose 0.3% to 2,683 pence in early London trading Friday, recovering from a 2.2% drop the previous day. Nigeria approved targeted incentives for Shell’s planned Bonga South West deepwater project, with officials citing a possible $20 billion investment. Shell has not confirmed the figure. The company is also exploring a sale of its Vaca Muerta shale assets in Argentina, sources said.
23 January 2026
···
UOL Group stock price slips as Singapore home prices cool; MAS policy update on Jan 29 in focus

UOL Group stock price slips as Singapore home prices cool; MAS policy update on Jan 29 in focus

UOL Group Ltd shares fell 0.3% to S$10.36 by mid-afternoon Friday, underperforming the Straits Times Index, which hit a record high. Urban Redevelopment Authority data showed private home prices rose 0.6% in Q4 2025, while rents slipped 0.5%. About 33,100 new units are expected to enter the market in the next two years. Singapore’s core inflation reached 1.2% year-on-year in December.
23 January 2026
····
SGX stock price rises as Singapore Exchange proposes smaller board lots; Feb 13 deadline looms

SGX stock price rises as Singapore Exchange proposes smaller board lots; Feb 13 deadline looms

Shares of Singapore Exchange rose 1.1% to S$17.49 Friday afternoon, near a 52-week high. SGX plans to cut standard board lot sizes for higher-priced securities, aiming to lower minimum investment amounts. The Monetary Authority of Singapore launched a S$5 billion initiative to support local equities, with S$1.1 billion allocated to asset managers. Public consultation on SGX’s proposal ends Feb. 13.
23 January 2026
·
India’s Q3 results rush: IndusInd Bank profit seen plunging as JSW Steel, BPCL, Cipla report today

India’s Q3 results rush: IndusInd Bank profit seen plunging as JSW Steel, BPCL, Cipla report today

Over 50 Indian companies, including IndusInd Bank, JSW Steel, BPCL, and Cipla, will report December-quarter earnings on Friday. Brokerages expect IndusInd Bank’s profit after tax to drop sharply, with forecasts ranging from 13 crore to 313 crore rupees. JSW Steel faces weaker prices, while BPCL may see higher EBITDA due to softer crude. Pharma and banking sectors remain under pressure.
23 January 2026
······
1 … 423 424 425 426 427 … 2,714

Stock Market Today

Pfizer stock price rises into weekend as FDA priority review, TrumpRx discounts grab focus

Pfizer stock price rises into weekend as FDA priority review, TrumpRx discounts grab focus

7 February 2026
New York, February 7, 2026, 05:48 EST — Market closed Pfizer Inc (PFE) shares ended Friday up 2.8% at $27.22, after trading between $26.52 and $27.37. About 50.7 million shares changed hands. (Yahoo Finance) The stock’s late-week lift comes with a key regulatory clock running: the FDA granted priority review for Pfizer’s supplemental filing to broaden use of its hemophilia drug Hympavzi, with a target decision deadline in the second quarter. Priority review shortens the agency’s standard review timeline by four months. “There is a significant medical need for younger patients with hemophilia and for those who have developed inhibitors,”
Go toTop